G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression

Background: Clear cell renal cell carcinoma (ccRCC) is a cell metabolic disease with high metastasis rate and poor prognosis. Our previous studies demonstrate that glucose-6-phosphate dehydrogenase (G6PD), the first and rate-limiting enzyme of the pentose phosphate pathway, is highly expressed in cc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiao, Ni, Yueli, Wang, Shujie, Agbana, Yannick Luther, Han, Qiaoqiao, Liu, Wenjing, Bai, Honggang, Yi, Zihan, Yi, Xiaojia, Zhu, Yuzhi, Sai, Buqing, Yang, Lijuan, Shi, Qiong, Kuang, Yingmin, Yang, Zhe, Zhu, Yuechun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692124/
https://www.ncbi.nlm.nih.gov/pubmed/34975298
http://dx.doi.org/10.7150/ijms.58902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692124/
https://www.ncbi.nlm.nih.gov/pubmed/34975298
http://dx.doi.org/10.7150/ijms.58902

Ejemplares similares